Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 8
2004 4
2005 5
2006 9
2007 9
2008 22
2009 16
2010 15
2011 14
2012 27
2013 20
2014 23
2015 16
2016 11
2017 6
2018 17
2019 12
2020 17
2021 15
2022 20
2023 11
2024 11
2025 13
2026 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

310 results

Results by year

Filters applied: . Clear all
Page 1
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe.
SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 working group and ESC Cardiovascular risk collaboration. Eur Heart J. 2021 Jul 1;42(25):2439-2454. doi: 10.1093/eurheartj/ehab309. Eur Heart J. 2021. PMID: 34120177 Free PMC article.
AIMS: The aim of this study was to develop, validate, and illustrate an updated prediction model (SCORE2) to estimate 10-year fatal and non-fatal cardiovascular disease (CVD) risk in individuals without previous CVD or diabetes aged 40-69 years in Europe. ...
AIMS: The aim of this study was to develop, validate, and illustrate an updated prediction model (SCORE2) to estimate 10-year fatal and non- …
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, Hamann F, Heidbüchel H, Hindricks G, Kautzner J, Kuck KH, Mont L, Ng GA, Rekosz J, Schoen N, Schotten U, Suling A, Taggeselle J, Themistoclakis S, Vettorazzi E, Vardas P, Wegscheider K, Willems S, Crijns HJGM, Breithardt G; EAST-AFNET 4 Trial Investigators. Kirchhof P, et al. Among authors: vardas p. N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29. N Engl J Med. 2020. PMID: 32865375 Clinical Trial.
BACKGROUND: Despite improvements in the management of atrial fibrillation, patients with this condition remain at increased risk for cardiovascular complications. It is unclear whether early rhythm-control therapy can reduce this risk. ...CONCLUSIONS: Early rhythm-control …
BACKGROUND: Despite improvements in the management of atrial fibrillation, patients with this condition remain at increased risk for card …
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.
Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ; ESC Scientific Document Group. Knuuti J, et al. Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425. Eur Heart J. 2020. PMID: 31504439 Free article. No abstract available.
Epidemiology of cardiovascular disease in Europe.
Townsend N, Kazakiewicz D, Lucy Wright F, Timmis A, Huculeci R, Torbica A, Gale CP, Achenbach S, Weidinger F, Vardas P. Townsend N, et al. Among authors: vardas p. Nat Rev Cardiol. 2022 Feb;19(2):133-143. doi: 10.1038/s41569-021-00607-3. Epub 2021 Sep 8. Nat Rev Cardiol. 2022. PMID: 34497402 Review.
This Review presents data describing the health burden of cardiovascular disease (CVD) within and across the WHO European Region. CVD remains the most common cause of death in the region. ...
This Review presents data describing the health burden of cardiovascular disease (CVD) within and across the WHO European Region. CVD …
European Society of Cardiology: cardiovascular disease statistics 2021.
Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, Gale CP, Maggioni AP, Petersen SE, Huculeci R, Kazakiewicz D, de Benito Rubio V, Ignatiuk B, Raisi-Estabragh Z, Pawlak A, Karagiannidis E, Treskes R, Gaita D, Beltrame JF, McConnachie A, Bardinet I, Graham I, Flather M, Elliott P, Mossialos EA, Weidinger F, Achenbach S; Atlas Writing Group, European Society of Cardiology. Timmis A, et al. Among authors: vardas p. Eur Heart J. 2022 Feb 22;43(8):716-799. doi: 10.1093/eurheartj/ehab892. Eur Heart J. 2022. PMID: 35016208 Free article.
AIMS: This report from the European Society of Cardiology (ESC) Atlas Project updates and expands upon the widely cited 2019 report in presenting cardiovascular disease (CVD) statistics for the 57 ESC member countries. METHODS AND RESULTS: Statistics pertaining to 2019, or …
AIMS: This report from the European Society of Cardiology (ESC) Atlas Project updates and expands upon the widely cited 2019 report in prese …
Economic burden of cardiovascular diseases in the European Union: a population-based cost study.
Luengo-Fernandez R, Walli-Attaei M, Gray A, Torbica A, Maggioni AP, Huculeci R, Bairami F, Aboyans V, Timmis AD, Vardas P, Leal J. Luengo-Fernandez R, et al. Among authors: vardas p. Eur Heart J. 2023 Dec 1;44(45):4752-4767. doi: 10.1093/eurheartj/ehad583. Eur Heart J. 2023. PMID: 37632363 Free PMC article.
BACKGROUND AND AIMS: Cardiovascular disease (CVD) impacts significantly health and social care systems as well as society through premature mortality and disability, with patients requiring care from relatives. ...
BACKGROUND AND AIMS: Cardiovascular disease (CVD) impacts significantly health and social care systems as well as society through pre …
European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics.
Timmis A, Aboyans V, Vardas P, Townsend N, Torbica A, Kavousi M, Boriani G, Huculeci R, Kazakiewicz D, Scherr D, Karagiannidis E, Cvijic M, Kapłon-Cieślicka A, Ignatiuk B, Raatikainen P, De Smedt D, Wood A, Dudek D, Van Belle E, Weidinger F; ESC National Cardiac Societies. Timmis A, et al. Among authors: vardas p. Eur Heart J. 2024 Oct 7;45(38):4019-4062. doi: 10.1093/eurheartj/ehae466. Eur Heart J. 2024. PMID: 39189413 Free article.
This report from the European Society of Cardiology (ESC) Atlas Project updates and expands upon the 2021 report in presenting cardiovascular disease (CVD) statistics for the ESC member countries. This paper examines inequalities in cardiovascular healthcare and out …
This report from the European Society of Cardiology (ESC) Atlas Project updates and expands upon the 2021 report in presenting cardiovasc …
Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease: A clinical consensus statement of the ESC Council on Cardiovascular Genomics, the ESC Cardiovascular Risk Collaboration, and the European Association of Preventive Cardiology.
Schunkert H, Di Angelantonio E, Inouye M, Patel RS, Ripatti S, Widen E, Sanderson SC, Kaski JP, McEvoy JW, Vardas P, Wood A, Aboyans V, Vassiliou VS, Visseren FLJ, Lopes LR, Elliott P, Kavousi M. Schunkert H, et al. Among authors: vardas p. Eur Heart J. 2025 Apr 15;46(15):1372-1383. doi: 10.1093/eurheartj/ehae649. Eur Heart J. 2025. PMID: 39906985 Free PMC article.
Genome-wide association studies have revealed hundreds of genetic variants associated with cardiovascular diseases (CVD). Polygenic risk scores (PRS) can capture this information in a single metric and hold promise for use in CVD risk prediction. ...
Genome-wide association studies have revealed hundreds of genetic variants associated with cardiovascular diseases (CVD). Polygenic r …
Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial.
Willems S, Borof K, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Gessler N, Goette A, Haegeli LM, Heidbuchel H, Kautzner J, Ng GA, Schnabel RB, Suling A, Szumowski L, Themistoclakis S, Vardas P, van Gelder IC, Wegscheider K, Kirchhof P. Willems S, et al. Among authors: vardas p. Eur Heart J. 2022 Mar 21;43(12):1219-1230. doi: 10.1093/eurheartj/ehab593. Eur Heart J. 2022. PMID: 34447995 Free PMC article. Clinical Trial.
Primary outcome was a composite of death from cardiovascular causes, stroke, or hospitalization with worsening of heart failure or acute coronary syndrome, analyzed in a time-to-event analysis. ...Anticoagulation and treatment of concomitant cardiovascular condition …
Primary outcome was a composite of death from cardiovascular causes, stroke, or hospitalization with worsening of heart failure or ac …
310 results